乳腺MR成像用于评估乳腺癌初次手术后切缘阳性患者的残留病变
本研究为回顾性研究,纳入175例乳腺癌初次手术后切缘阳性并接受术后MR检查的患者,由两名专家独立评估手术腔残留病变及多灶/多中心病变,并与最终手术病理对照。结果显示,术后乳腺MR能准确显示手术腔≥5 mm的残留病变及未知的多灶/多中心病变,可能有助于更恰当地选择二次手术方式。
要点
- 术后乳腺MR可准确显示手术腔≥5 mm的残留病变。
- 手术腔残留病变的敏感度在浸润性癌和导管原位癌中均较高。
- 术后改变与非常小的残留病变(<5 mm)可能存在重叠。
核心结论
- 术后乳腺MR能准确显示手术腔≥5 mm的残留病变及未知的多灶/多中心病变,这些发现可能有助于更恰当地选择切缘阳性女性的二次手术方式。
研究设计与样本
- 经IRB批准、符合HIPAA的回顾性研究,纳入175例乳腺癌初次手术后切缘阳性并接受MR检查的患者,两名专家独立重新评估MR图像,所有患者均接受确定性手术并将MR表现与组织病理学对照。
关键影像表现/征象
- 手术腔残留病变的总体平均敏感度、特异度、PPV和NPV分别为73%、72%、91%和45%。
- 读者1识别出42/45(93%)手术腔残留浸润性病变≥5 mm的患者,读者2识别出43/45(95%)。
- 两名读者均识别出22/22(100%)病变≥10 mm的患者。
- 未知多灶/多中心病变的平均敏感度、特异度、PPV和NPV分别为90%、96%、93%和86%。
诊断标准与关键数值
- 手术腔残留病变≥5 mm:读者1敏感度93%(42/45),读者2敏感度95%(43/45)。
- 手术腔残留病变≥10 mm:两名读者敏感度均为100%(22/22)。
- 手术腔残留病变总体平均敏感度73%、特异度72%、PPV 91%、NPV 45%。
- 未知多灶/多中心病变平均敏感度90%、特异度96%、PPV 93%、NPV 86%。
临床应用与阅片要点
- 术后乳腺MR可准确显示手术腔≥5 mm的残留病变,阅片时应关注手术腔≥5 mm的残留病变。
- 术后改变与非常小的残留病变(<5 mm)可能存在重叠,阅片时需注意鉴别。
- 术后乳腺MR可能有助于规划准确的再切除。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine the accuracy of post-operative MR in predicting residual disease in women with positive margins, emphasizing the size thresholds at which residual disease can be confidently identified.
METHODS: This IRB-approved HIPAA-compliant retrospective study included 175 patients with MR after positive margins following initial surgery for breast cancer. Two expert readers independently re-evaluated MR images for evidence of residual disease at the surgical cavity and multifocal/multicentric disease. All patients underwent definitive surgery and MR findings were correlated to histopathology.
RESULTS: 139/175 (79.4%) patients had residual disease at surgery. Average overall sensitivity, specificity, PPV and NPV for residual disease at the surgical cavity were 73%, 72%, 91% and 45%, respectively. The readers identified 42/45 (93%, reader 1) and 43/45 (95%, reader 2) patients with residual invasive disease at the cavity of ≥5 mm and 22/22 (100%, both readers) patients with disease ≥10 mm. Average sensitivity, specificity, PPV and NPV for unknown multifocal/multicentric disease were 90%, 96%, 93% and 86%, respectively.
CONCLUSIONS: Post-operative breast MR can accurately depict ≥5-mm residual disease at the surgical cavity and unsuspected multifocal/multicentric disease. These findings have the potential to lead to more appropriate selection of second surgical procedures in women with positive margins.
KEY POINTS: • Post-operative breast MRI accurately defines residual disease of ≥5 mm. • Surgical cavity sensitivities were high for both invasive carcinoma and DCIS. • Post-surgical changes and very small residual disease (<5 mm) may overlap. • Post-operative breast MRI may help planning an accurate re-resection.
引用
- Krammer J, Price ER, Jochelson MS, et al. Breast MR imaging for the assessment of residual disease following initial surgery for breast cancer with positive margins. Eur Radiol. 2017. PMID: 28567547. doi:10.1007/s00330-017-4823-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。